KCS notified as authorised body to inspect medical devices manufacturing facilities
Among the 14 such notified bodies nationwide, KCS is the only one operational in Andhra Pradesh and Telangana, marking a milestone in the region's quality management capabilities.
Founded in July 2017, the KIHT, located on the AMTZ campus, is a Central government project supported by the Department of Biotechnology. It promotes and supports innovations in medical technologies through research and development, industry promotion, policy-making and knowledge repository.
Founded in April 2022, the KCS is accredited by the National Accreditation Board for Certification Bodies (NABCB).
The organisation offers comprehensive services, including ISO- 13485 certification, quality systems audit, risk management training, and CE‐mark consultancy — making it a full service hub for manufacturers seeking to meet global regulatory standards.
This approval brings immediate benefits to domestic manufacturers, particularly the MSMEs, by eliminating the need for audits outside the State — resulting in significant time and cost savings.
It also reinforces Andhra Pradesh's MedTech credentials, supporting national campaigns like 'Make in India' and 'ACI manufacturing', while making the region highly attractive for future investments.
This significant milestone empowers KCS to conduct independent regulatory audits for medical device manufacturers in accordance with the Medical Devices Rules (MDR)-2017 for Class A (low risk) and Class B (moderate risk), the release added, while underscoring the State's reputation as a business-friendly hub, ready to meet rising global demand in healthcare.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
an hour ago
- Time of India
Deemed univs with lower fees emerge as top choices for MBBS
Chennai: Deemed universities that charge lower fees, even if they are new, were among the first choices of candidates aspiring to become doctors, as shown by the results of the round 1 counselling released by the Medical Counselling Committee. The committee, led by the Directorate General of Health Services, allots seats online to students based on merit in NEET and the rule of reservation for 15% of seats under the all-India quota in state-run colleges, all central govt institutions, and deemed universities. Students are required to choose and lock in their preferred medical colleges in order of preference. You Can Also Check: Chennai AQI | Weather in Chennai | Bank Holidays in Chennai | Public Holidays in Chennai | Gold Rates Today in Chennai | Silver Rates Today in Chennai Overall, the cut-off for All-India rank and NEET score was higher in 2025 at 215/720 marks in NEET 2025 (7.3 lakh all-India rank) compared to 135/720 marks in NEET 2024 (13.3 lakh all-India rank). "Although toppers' scores were lower, there was crowding in scores between 400-500," said R Saravanakumar, a NEET coach at a private institution. Analysis of round 1 counselling results, however, showed the most opted medical college among deemed universities in the country is Kasturba Medical College, Manipal University in Manipal, which charges around 17.7 lakh every year. The cut-offs in this college were the first to close at the all-India rank of 40008 with a NEET-2025 score of 511/720. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like This Could Be the Best Time to Trade Gold in 5 Years IC Markets Learn More Undo The college was followed by Symbiosis Medical College for Women in Pune (47592 rank and 504 marks) and Kasturba Medical College, Manipal University, Mangalore (52466 rank and 500 marks). Tamil Nadu colleges, which charge up to 30.5 lakh per year, were not among the top 20 choices of students. While colleges from Karnataka and Maharashtra were among the top 10 colleges to close early, a student with a rank of 263126 and 374 marks in NEET was the last to be given a seat at TN's Sri Ramachandra Medical College. "When tuition fees per year are around 30 lakh, the overall fee for four years is nearly 1.2 crore. Parents may have to pay another 10-15 lakh more for boarding, lodging, books, and other fees," said student counsellor Manickavel Arumugam. Stay updated with the latest local news from your city on Times of India (TOI). Check upcoming bank holidays , public holidays , and current gold rates and silver prices in your area.
The Print
3 days ago
- The Print
Health Ministry launches SHRESTH index to strengthen state drug regulatory systems
The initiative, proposed by the Central Drugs Standard Control Organisation (CDSCO), aims to improve the performance of state drug regulatory authorities, ensuring that drug safety and quality standards are consistently met, the ministry said in a statement. The index was launched on Tuesday by Union Health Secretary Punya Salila Srivastava virtually in the presence of Drug Controller General of India Dr Rajeev Singh Raghuvanshi. New Delhi, Aug 13 (PTI) The Union Health Ministry has launched the State Health Regulatory Excellence Index, a first-of-its-kind national initiative to benchmark and strengthen state drug regulatory systems through a transparent and data-driven framework. In a meeting attended virtually by the health secretaries, principal health secretaries and the drugs controllers from states and Union Territories, Srivastava reiterated that the health of all citizens begins with the safety, quality, and efficacy of the medicines they consume. Ensuring their quality is the government's commitment, she said. 'Our federal structure is designed to regulate a complex and globally significant pharmaceutical industry. The only way forward is cooperative action to ensure medicines made in India are trusted everywhere, starting with every citizen in India,' the Union health secretary said. Srivastava highlighted the crucial role played by states and Union Territories in ensuring quality manufacturing and distribution in India and the need for recognising and supporting their best practices and growth. 'States have strong regulatory certification. State Health Regulatory Excellence Index (SHRESTH) is a virtual gap assessment tool for states to assess their current position and help towards maturity certification,' she added. Highlighting India's achievement of WHO ML3 status for vaccines, Srivastava stressed the next step is to elevate medicines to the same global standard, advancing international harmonisation and reinforcing India's role as the 'pharmacy of the world'. Several upcoming initiatives were also outlined, including the extension of the Not of Standard Quality (NSQ) dashboard to all states, the proposed symposium on Drug Regulatory Systems, and the expansion of joint training and audits. Speaking on the occasion, Dr Raghuvanshi highlighted that states will be divided into two categories — manufacturing and primarily distribution — and will be ranked accordingly on the SHRESTH index. SHRESTH will have 27 indices for Manufacturing States across five key themes — human resources, infrastructure, licensing activities, surveillance activities and responsiveness — and 23 indices for primarily distribution states. States will submit the data on predefined metrics to CDSCO, which will be collected by the 25th day of every month, and these metrics will be scored on the first day of next month and shared with all states and Union Territories, Dr Raghuvanshi said. PTI PLB NSD NSD This report is auto-generated from PTI news service. ThePrint holds no responsibility for its content.
Time of India
4 days ago
- Time of India
CDSCO notifies draft standard evaluation protocols for issuing IVD licenses
New Delhi: India's medical device regulator, CDSCO in collaboration with the Indian Council of Medical Research (ICMR) has issued draft standard protocols for evaluating In-Vitro Diagnostics (IVDs) devices quality and performance, to be used for issuing licenses. The protocols are meant to be followed by the country's IVD manufacturers testing labs and the regulator has sought stakeholders' comments over the notified draft by August 25. 'These protocols are now being placed in the public domain for comments from relevant stakeholders. This window of opportunity will close on 25th August 2025, and, once finalized, there will be minimal scope for change in these documents,' the notice reads. The 180-page document details the standard performance evaluation and field evaluation protocol for 15 types of IVDs including Dengue, Malaria, Influenza virus, Nipah virus, Chandipura virus, SARS-CoV-2 molecular detection differentiation assay, among several others. In Vitro Diagnostics (IVDs) are medical devices used to test samples such as blood, urine, or tissue outside the human body, to diagnose diseases, conditions, or infections, and to monitor a person's health based on predefined bio markers. Under the Medical Device Rules of 2017, 'Licensure of In-Vitro Diagnostics (IVDs) requires a detailed evaluation protocol for the performance evaluation of IVDs to evaluate their quality and performance.' The evaluation protocol helps to test the device safety, sensitivity, and accuracy, to validate the device clinical and analytical performance, required for issuing the product license, thereby allowing its usage in the country. In India the ICMR develops evaluation protocols to standardize the process of assessing the performance of diagnostic kits, particularly In Vitro Diagnostics (IVDs) and the CDSCO oversees the evaluation and enforcement of the protocols.
